Type II Kinase Inhibitors Targeting Cys-Gatekeeper Kinases Display Orthogonality with Wild Type and Ala/Gly-Gatekeeper Kinases. (2018)
Attributed to:
Alignment of Synthesis, Medicinal Chemistry and Structural Genomics to Accelerate UK Drug Discovery: Network SMS-Drug
funded by
EPSRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1021/acschembio.8b00592
PubMed Identifier: 30239186
Publication URI: http://europepmc.org/abstract/MED/30239186
Type: Journal Article/Review
Volume: 13
Parent Publication: ACS chemical biology
Issue: 10
ISSN: 1554-8929